VVOS logo

Vivos Therapeutics, Inc. (VVOS)

Profile

Full Name

Vivos Therapeutics, Inc.

Ticker

NASDAQ: VVOS

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

December 11, 2020

Indexes

Not included

Website

https://www.vivos.com

Employees

113

Key Details

Price

$2.36(-4.45%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$15.03M(8.91% YoY)

Annual EPS

-$2.22(80.08% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.36
    VVOS price is $2.36

    30-Day Relative Volume

    0.37
    VVOS 30-day relative volume is 0.37

    Price Performance

    Price Most Recent Change

    -4.45%
    VVOS price was down -4.45% on Nov 19, 2025

    Price YTD Change

    -44.99%
    VVOS price is down -44.99% since January 1st

    Price 1-Year Change

    -18.34%
    VVOS price is down -18.34% year-on-year

    Price 3-Year Change

    -84.55%
    VVOS price is down -84.55% over the past 3 years

    Price Range

    Price All-Time High

    $360.25
    VVOS price is currently -99.34% below its historical high of $360.25

    Price 3-Year Low

    $1.91
    VVOS price is currently +23.56% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $17.71M
    VVOS market cap is $17.71 million

    Market Cap 3-Year Change

    +25.96%
    VVOS market cap is up +25.96% over the past 3 years

    Market Cap All-Time High

    $176.11M
    VVOS market cap is currently -89.94% below its historical high of $176.11 million

    Market Cap Sector Percentile

    22.09%
    VVOS market cap is higher than 22.09% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +55.21%
    VVOS shares outstanding is up +55.21% year-on-year

    Shares Outstanding 3-Year Change

    +715.3%
    VVOS shares outstanding is up +715.3% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.78
    VVOS beta is 0.78

    200-day SMA

    $3.40
    VVOS price is currently -30.61% below its 200-day simple moving average

    50-day SMA

    $2.94
    VVOS price is currently -19.71% below its 50-day simple moving average

    14-Day RSI

    38.01
    VVOS 14-day relative strength index is 38.01

    Volume

    0.37
    VVOS 30-day relative volume is 0.37

    ATR

    $0.20
    VVOS average true range is $0.20

    10-day Historical Volatility

    76.91%
    VVOS 10-day historical volatility is 76.91%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $15.03M
    VVOS annual revenue is $15.03 million

    Revenue Analysts Estimate

    $16.50M
    VVOS annual revenue is currently -8.91% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +8.91%
    VVOS annual revenue is up +8.91% year-on-year

    Revenue Sector Percentile

    51.56%
    VVOS annual revenue is higher than 51.56% of companies in Healthcare sector

    EPS

    EPS

    -$2.22
    VVOS annual earnings per share is -$2.22

    EPS Analysts Estimate

    -$1.88
    VVOS annual earnings per share is currently -18.31% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +80.08%
    VVOS annual earnings per share is up +80.08% year-on-year

    EPS Sector Percentile

    37.15%
    VVOS annual earnings per share is higher than 37.15% of companies in Healthcare sector

    Profit

    Gross Profit

    $9.02M
    VVOS annual gross profit is $9.02 million

    Gross Margin

    60.00%
    VVOS annual gross profit margin is 60.00%

    Operating Profit

    -$11.17M
    VVOS annual operating income is -$11.17 million

    Operating Margin

    -74.32%
    VVOS annual operating profit margin is -74.32%

    Net Income

    -$11.14M
    VVOS annual net profit is -$11.14 million

    Net Margin

    -74.09%
    VVOS annual net profit margin is -74.09%

    Expenses

    Total Expenses

    $26.20M
    VVOS annual total expenses is $26.20 million

    Operating Expenses

    $20.19M
    VVOS annual total operating expenses is $20.19 million

    Cost Of Goods Sold

    $6.01M
    VVOS annual cost of goods sold is $6.01 million

    Selling, General & Administrative Expenses

    $19.61M
    VVOS annual SG&A is $19.61 million

    Depreciation & Amortization

    $581.00K
    VVOS annual D&A is $581.00 thousand

    Interest Expense

    $0.00
    VVOS annual interest expense is $0.00

    Income Tax

    $0.00
    VVOS annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$11.17M
    VVOS annual earnings before interest & taxes is -$11.17 million

    EBITDA

    -$10.59M
    VVOS annual EBITDA is -$10.59 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $15.28M
    VVOS annual total assets is $15.28 million

    Non Current Assets

    $7.81M
    VVOS annual long term assets is $7.81 million

    Current Assets

    $7.47M
    VVOS annual total current assets is $7.47 million

    Cash and Cash Equivalents

    $6.26M
    VVOS annual cash & cash equivalents is $6.26 million

    Accounts Receivable

    $430.00K
    VVOS annual accounts receivable is $430.00 thousand

    Inventory

    $0.00
    VVOS annual inventory is $0.00

    Liabilities

    Total Liabilities

    $7.33M
    VVOS annual total liabilities is $7.33 million

    Long Term Liabilities

    $2.35M
    VVOS annual total long term liabilities is $2.35 million

    Current Liabilities

    $4.98M
    VVOS annual current liabilities is $4.98 million

    Accounts Payable

    $1.10M
    VVOS annual accounts payable is $1.10 million

    Debt

    Total Debt

    $1.51M
    VVOS annual total debt is $1.51 million

    Total Debt 1-Year Change

    -24.21%
    VVOS annual total debt is down -24.21% year-on-year

    Long Term Debt

    $1.03M
    VVOS annual long term debt is $1.03 million

    Short Term Debt

    $477.00K
    VVOS annual short term debt is $477.00 thousand

    Equity & Capital

    Shareholders Equity

    $7.95M
    VVOS annual stockholders equity is $7.95 million

    Book Value

    $7.95M
    VVOS annual book value is $7.95 million

    Retained Earnings

    -$104.19M
    VVOS annual retained earnings is -$104.19 million

    Working Capital

    $2.50M
    VVOS annual working capital is $2.50 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$12.69M
    VVOS annual cash from operations is -$12.69 million

    Cash From Operations 1-Year Change

    -6.24%
    VVOS annual cash from operations is down -6.24% year-on-year

    Cash From Investing

    -$568.00K
    VVOS annual cash from investing is -$568.00 thousand

    Cash From Investing 1-Year Change

    +33.41%
    VVOS annual cash from investing is up +33.41% year-on-year

    Cash From Financing

    $17.88M
    VVOS annual cash from financing is $17.88 million

    Cash From Financing 1-Year Change

    +63.65%
    VVOS annual cash from financing is up +63.65% year-on-year

    CAPEX

    CAPEX

    $568.00K
    VVOS annual capital expenditures is $568.00 thousand

    CAPEX 1-Year Change

    -29.27%
    VVOS annual capital expenditures is down -29.27% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$13.26M
    VVOS annual free cash flow is -$13.26 million

    Free Cash Flow 1-Year Change

    -4%
    VVOS annual free cash flow is down -4% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    60.00%
    VVOS annual gross profit margin is 60.00%

    Operating Margin

    -74.32%
    VVOS annual operating profit margin is -74.32%

    Net Margin

    -74.09%
    VVOS annual net profit margin is -74.09%

    ROA & ROE

    ROA

    -85.62%
    VVOS annual return on assets is -85.62%

    ROE

    -266.25%
    VVOS annual return on equity is -266.25%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    VVOS price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    VVOS price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    3.86
    VVOS price to book ratio is 3.86

    PB Ratio Sector Percentile

    70.01%
    VVOS price to book ratio is higher than 70.01% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    1.23
    VVOS price to sales ratio is 1.23

    PS Ratio Sector Percentile

    25.49%
    VVOS price to sales ratio is higher than 25.49% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $24.89M
    VVOS enterprise value is $24.89 million

    Enterprise Value Sector Percentile

    29.57%
    VVOS enterprise value is higher than 29.57% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.85
    VVOS EV/EBITDA is -1.85

    EV/EBITDA Sector Percentile

    39.1%
    VVOS EV/EBITDA is higher than 39.1% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    1.50
    VVOS annual current ratio is 1.50

    Quick Ratio

    1.50
    VVOS annual quick ratio is 1.50

    Leverage

    Debt To Equity

    0.00
    VVOS annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -
    VVOS annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    0
    VVOS piotroski f-score is 0

    Altman Z-Score

    -9.33
    VVOS altman z-score is -9.33

    Analyst ratings

    Recent major analysts updates

    Sep 9, 25 Ascendiant Capital
    Buy
    Apr 15, 25 Ascendiant Capital
    Buy
    Nov 20, 24 Ascendiant Capital
    Buy
    Nov 19, 24 Alliance Global Partners
    Buy
    Aug 20, 24 Ascendiant Capital
    Buy
    Jan 17, 23 Ascendiant Capital
    Buy
    Aug 13, 21 Roth Capital
    Buy
    May 18, 21 Roth Capital
    Buy
    Jan 11, 21 Craig-Hallum
    Buy
    Jan 5, 21 Roth Capital
    Buy

    Institutional Ownership

    Screeners with VVOS included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Earnings this week
    • What is the ticker symbol for Vivos Therapeutics, Inc.?
    • Does Vivos Therapeutics, Inc. pay dividends?
    • What sector is Vivos Therapeutics, Inc. in?
    • What industry is Vivos Therapeutics, Inc. in?
    • What country is Vivos Therapeutics, Inc. based in?
    • When did Vivos Therapeutics, Inc. go public?
    • Is Vivos Therapeutics, Inc. in the S&P 500?
    • Is Vivos Therapeutics, Inc. in the NASDAQ 100?
    • Is Vivos Therapeutics, Inc. in the Dow Jones?
    • When was Vivos Therapeutics, Inc.'s last earnings report?
    • When does Vivos Therapeutics, Inc. report earnings?

    What is the ticker symbol for Vivos Therapeutics, Inc.?

    The ticker symbol for Vivos Therapeutics, Inc. is NASDAQ:VVOS

    Does Vivos Therapeutics, Inc. pay dividends?

    No, Vivos Therapeutics, Inc. does not pay dividends

    What sector is Vivos Therapeutics, Inc. in?

    Vivos Therapeutics, Inc. is in the Healthcare sector

    What industry is Vivos Therapeutics, Inc. in?

    Vivos Therapeutics, Inc. is in the Medical Devices industry

    What country is Vivos Therapeutics, Inc. based in?

    Vivos Therapeutics, Inc. is headquartered in United States

    When did Vivos Therapeutics, Inc. go public?

    Vivos Therapeutics, Inc.'s initial public offering (IPO) was on December 11, 2020

    Is Vivos Therapeutics, Inc. in the S&P 500?

    No, Vivos Therapeutics, Inc. is not included in the S&P 500 index

    Is Vivos Therapeutics, Inc. in the NASDAQ 100?

    No, Vivos Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Vivos Therapeutics, Inc. in the Dow Jones?

    No, Vivos Therapeutics, Inc. is not included in the Dow Jones index

    When was Vivos Therapeutics, Inc.'s last earnings report?

    Vivos Therapeutics, Inc.'s most recent earnings report was on November 19, 2025

    When does Vivos Therapeutics, Inc. report earnings?

    The date for Vivos Therapeutics, Inc.'s next earnings report has not been announced yet
    On this page